Paasa Logo
vTv Therapeutics Inc. logo
VTVTNASDAQMarket closedOpens 9:30am ET

vTv Therapeutics Inc.

$30.00Last updated
-$0.52 (1.70%)Past day
Timezone

vTv Therapeutics Inc. (NASDAQ: VTVT) is trading at $30.00, about ₹2,882 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 1.70% today. Indian residents can buy vTv Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$30.90
Previous close:$30.52
Volume:85.14K

Today's low

$30.00

Today's high

$30.90

52 week low

$19.50

52 week high

$44.00

VTVT opened at $30.90, closed previously at $30.52, and has traded between $19.50 and $44.00 over the past 52 weeks.

About

vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodiesterase type 4 (PDE4) inhibitor that does not cross the blood-brain barrier (non-CNS penetrant), designed to treat inflammatory conditions and psoriasis. Beyond these, vTv Therapeutics' broader clinical portfolio includes: TTP273, an oral small-molecule GLP-1 receptor agonist addressing postprandial glucose excursions in cystic fibrosis-related diabetes. HPP3033, which employs a non-electrophilic strategy to activate the Nrf2 pathway for chronic conditions linked to oxidative stress. Azeliragon, a RAGE antagonist being evaluated for inflammatory lung disorders, notably severe COVID-19, alongside pancreatic and breast cancers. HPP971, an Nrf2 activator aimed at renal diseases, developed in collaboration with pharmaceutical partners. Furthermore, vTv holds a licensing agreement with Reneo Pharmaceuticals, Inc. for the development and commercialization of its peroxisome proliferation-activated receptor delta agonist program, which features the compound HPP593. The company has also established various other licensing and research collaborations with entities such as Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Newsoara Biopharma Co., Ltd., JDRF International, and Novo Nordisk A/S. Established in 2015, vTv Therapeutics is headquartered in High Point, North Carolina, and operates as a subsidiary of MacAndrews & Forbes Incorporated.

Country
US
CEO
Paul J. Sekhri
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
26
Sector
Healthcare
IPO date
30/07/2015

Key statistics

Avg. volume

64.28K

Market cap

$78.52M

P/E Ratio

-272.73

Price-to-sales ratio

2.13

Enterprise value

$247.93M

Free cash flow yield

-7.50%

Debt-to-equity ratio

0.00

Return on equity

-41.86%

ROIC

-39.41%

Beta

0.28

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$0.00

Earnings per share

-$3.20

Free cash flow

-$25.25M

Net profit margin

-12.91%

Gross margin

100.00%

EBITDA

-$31.06M

Revenue growth

-100.00%

Similar securities

This is not an investment recommendation

How to buy vTv Therapeutics from India

Indian residents can buy vTv Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for vTv Therapeutics and place an order

    Find vTv Therapeutics by name or by its ticker, VTVT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. vTv Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your vTv Therapeutics position in USD and INR. vTv Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in vTv Therapeutics from India

Trading and taxes when buying vTv Therapeutics from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NonevTv Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy vTv Therapeutics stock?

Yes. vTv Therapeutics (VTVT) has been listed on NASDAQ since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one vTv Therapeutics share cost in rupees?

One vTv Therapeutics share is $30.00 — about ₹2,882 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the vTv Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying vTv Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of vTv Therapeutics?

Yes. One vTv Therapeutics share is $30.00, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in vTv Therapeutics.

How are gains on vTv Therapeutics shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the vTv Therapeutics price. Paasa issues a capital-gains statement for your return.

Does vTv Therapeutics pay a dividend?

No. vTv Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade vTv Therapeutics from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on vTv Therapeutics shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare vTv Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your vTv Therapeutics holding, its cost and its closing value.

How do I sell vTv Therapeutics and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.